alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
(September 29, 2006)

#### The People of the State of New York, Respondent, v Philip S.A. Barnes, Appellant.

[821 NYS2d 541]

Appeal from a judgment of the Genesee County Court (Robert C. Noonan, J.), rendered September 24, 2004. The judgment convicted defendant, upon his plea of guilty, of burglary in the third degree.

It is hereby ordered that the judgment so appealed from be and the same hereby is affirmed.

Memorandum: On appeal from a judgment convicting him, *1251upon his plea of guilty, of burglary in the third degree (Penal Law § 140.20), defendant contends that County Court erred in denying his motion to withdraw his guilty plea. Upon our review of the record, we conclude that defendant did not in fact move to withdraw his plea, and we reject his further contention that the court afforded him the opportunity to withdraw his plea but then refused to grant him that relief. The further contention of defendant that he was denied effective assistance of counsel does not survive his plea of guilty inasmuch as “[t]here is no showing that the plea bargaining process was infected by any allegedly ineffective assistance or that defendant entered the plea because of his attorney[’s] allegedly poor performance” *(People v Burke,*256 AD2d 1244, 1244 [1998], *lv denied*93 NY2d 851 [1999]). The sentence is not unduly harsh or severe. We have considered defendant’s remaining contention and conclude that it is without merit.

All concur, Hayes, J., not participating. Present — Hurlbutt, J.P, Scudder, Kehoe, Gorski and Hayes, JJ.
#### § 300.2 General requirement.

Each and every wool product subject to the act shall be marked by a stamp, tag, label, or other means of identification, in conformity with the requirements of the act and the rules and regulations thereunder.
### §10269. Authorization of appropriations

Notwithstanding subsection (d) of section 10222 of this title, and subject to subsection (e) of such section, there are authorized to be appropriated for expenditures from amounts in the Waste Fund established in subsection (c) of such section such sums as may be necessary to carry out the provisions of this subchapter.

(Pub. L. 97–425, title V, §509, as added Pub. L. 100–202, §101(d) [title III], Dec. 22, 1987, 101 Stat. 1329–104, 1329–121; Pub. L. 100–203, title V, §5051, Dec. 22, 1987, 101 Stat. 1330–251.)

#### **Editorial Notes**

#### Codification

Pub. L. 100–202 and Pub. L. 100–203 added identical sections.
From: Carlson, Sara <Sara.Carlson@anadarko.com>

Sent: Saturday, July 12, 2014 10:25 AM

To: Lloyd, David; Dressler, Jason; Fortin, Kelly; Land, Eva; McNeal, Dave

Cc: Grygar, Bill; Maness, Katie; Rahul Pendse 

(rpendse@trinityconsultants.com); JSerne@trcsolutions.com

Subject: Emissions Testing Report for the Main Engines on the Diamond BlackHawk 

- Anadarko Petroleum Corporation

Attachments: Emissions Test of the Main Engines on the Diamond BlackHawk -

Anadarko Petroleum Corporation.pdf

Good morning. Attached is the Emissions Testing Report for the Diamond BlackHawk. Due to the size of 

the report I haven’t included the appendices. A paper copy and cd of the full report with appendices will 

be shipped out to the EPA Region 4 office address on Monday, July 14. 

Please acknowledge you have received this email and if you have any questions please feel free to 

contact me.

Thanks,

Sara Carlson

Anadarko Petroleum Corporation

Sr HSE Representative, Gulf of Mexico

Sara.Carlson@anadarko.com

832-636-1273 (office)

832-506-0888 (cell)

Click here for Anadarko’s Electronic Mail Disclaimer
[Federal Register Volume 84, Number 21 (Thursday, January 31, 2019)]
[Notices]
[Page 786]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00349]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Fellowships in Diabetes, 
Endocrinology and Metabolic Diseases.
    Date: February 12-13, 2019.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Thomas A. Tatham, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7021, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-3993, <a href="/cdn-cgi/l/email-protection#7004110418111d04301d11191c5e1e19185e171f06"><span class="__cf_email__" data-cfemail="433722372b222e37032e222a2f6d2d2a2b6d242c35">[email protected]</span></a>.

    This meeting notice is being published less than 15 days in 
advance of the meeting due to the partial Government shutdown of 
December 2018.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: January 25, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-00349 Filed 1-30-19; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
No: 13-050 June 10, 2013

CONTACT: Dave McIntyre, 301-415-8200 

NRC Seeks Public Comment on Foreign Ownership of Nuclear Power Plants;

Public Meeting June 19 in Rockville, Md.

The Nuclear Regulatory Commission is seeking public comment on issues related to foreign 

ownership, control and domination of commercial nuclear power plants, and will hold a public meeting 

June 19 at agency headquarters in Rockville, Md., to discuss the topic.

The Atomic Energy Act and NRC regulations disqualify any applicant for a nuclear power 

plant operating license if the applicant is owned, controlled or dominated by a foreign national, a foreign 

corporation or a foreign government. In recent years, a number of licensing actions before the NRC 

have involved complex issues of foreign ownership, control and domination. This is likely due to the 

increased globalization of the electric power industry and complexity of corporate structures generally.

The Commission directed the staff in March to prepare a fresh assessment of foreign 

ownership issues and propose any changes to guidance or practice that may be warranted. The staff’s 

assessment and proposals are due to the Commission by Dec. 31. At this time, no specific changes to 

guidance or regulation are under consideration. The staff requested public comment, with specific 

questions about the extent of indirect foreign ownership that should be allowed, in a notice published 

June 3 in the Federal Register. 

The June 19 public meeting will be held in the Commission Hearing Room, One White Flint 

North, 11555 Rockville Pike, from 9 a.m. to noon. For more information, see the public meeting notice. 

Written comments will be accepted through Aug. 2. They may be submitted over the federal 

government’s Rulemaking website at www.regulations.gov using Docket ID NRC-2013-0107, or by

mail to Cindy Bladey, Chief, Rules, Announcements, and Directives Branch, Office of Administration, 

Mail Stop: TWB-05-B01M, U.S. Nuclear Regulatory Commission, Washington, DC, 20555-0001.
### SUBCHAPTER II—ESTABLISHMENT OF CORPORATION
Exhibit
32.1

CERTIFICATION
PURSUANT TO18 U.S.C. SECTION 1350,

AS
ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In
connection with the Quarterly Report of Caliber Energy, Inc. on Form 10-QSB for the period
ending March 31, 2007, as filed with the Securities and Exchange Commission on the date
hereof (the Report), I, Graeme Scott, Principal Executive Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

| | (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the
               Securities Exchange Act of 1934; and
| | --- | ------------------------------------------------------------------------------------------------------------------------------------

| | (2) | the information contained in the Report fairly presents, in all material
               respects, the financial condition and result of operations of the Company.
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------

/S/ Graeme Scott
Graeme Scott President, C.E.O., and Director (Principal
Executive Officer)

May 7, 2007

A signed original of this written
statement required by Section 906, or other document authenticating, acknowledging, or
otherwise adopting the signature that appears in typed form within the electronic version
of this written statement has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission or its staff upon request.

---
#### Diane L. Dribben, Respondent-Appellant, v. Lafay Dribben, Appellant-Respondent.

In our opinion, the facts established by plaintiff were insufficient to warrant a judgment of separation on any of the grounds set forth in section 1161 of the Civil Practice Act. (Cf. *Smith*v. *Smith,*273 N. Y. 380; *Pearson*v. *Pearson,*230 N. Y. 141, 148, and *Umbach*v. *Umbach,*183 App. Div. 495.) No formal findings of fact were made below. The findings of fact contained in the trial court’s decision are affirmed, except insofar as the court may have found that the *“*defendant in effect told the plaintiff to leave him ”; and this court finds that such a demand was not made by defendant, nor may it reasonably be inferred from the testimony. Nolan, P. J., Carswell, Johnston, Sneed and MacCrate, JJ., concur.
Home > NRC Library > ADAMS Public Documents

# SRM-SECY-15-0141: Denial of Petition for Rulemaking Requesting Amendments Regarding Programmable Logic Computers (PRM-73-17)

Accession Number: ML16110A175

Date Released: Thursday, June 2, 2016

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.
    - ML16110A187 - SRM-SECY-15-0141:  Denial of Petition for Rulemaking Requesting Amendments Regarding Programmable Logic Computers (PRM-73-17) (1 page(s), 4/18/2016)
    - ML16110A191 - SRM-SECY-15-0141:  Enclosure 1 - Denial of Petition for Rulemaking Requesting Amendments Regarding Programmable Logic Computers (PRM-73-17) (12 page(s), 4/18/2016)
    - ML16110A207 - SRM-SECY-15-0141:  Enclosure 2 - Denial of Petition for Rulemaking Requesting Amendments Regarding Programmable Logic Computers (PRM-73-17) (1 page(s), 4/18/2016)

Privacy PolicySite Disclaimer
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Integrative, Functional and Cognitive Neuroscience Integrated Review Group; Neurobiology of Learning and Memory Study Section.                    

*Date:*                         February 19, 2019.                    

*Time:*                         8:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         The Westgate Hotel, 1055 Second Avenue, San Diego, CA 92101.                    

*Contact Person:*                         Alexei Kondratyev, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301-435-1785,                         *kondratyevad@csr.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: January 25, 2019.

Ronald J. Livingston, Jr.,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2019-00322 Filed 1-30-19; 8:45 am]

 BILLING CODE 4140-01-P
§ 301.45 Representations as to construction of fur products. ( a ) No misleading nor deceptive statements as to the construction of fur products shall be used directly or indirectly in labeling, invoicing or advertising such products. (For example, a fur product made by the skin-on-skin method should not be represented as having been made by the letout method.)
( b ) Where a fur product is made by the method known in the trade as letting-out, or is made of fur which has been sheared or plucked, such facts may be set out in labels, invoices and advertising.
#### Herman Rakov, Appellant, v. Bankers' Life Insurance Company of New York City, Respondent.

It appearing that there are not four justices qualified to sit in this appeal, the same is transferred to the Appellate División, Third Department, to be there heard and determined, pursuant to section 231 of the Code of Civil Procedure.
§ 1633.10 Definitions. ( a ) *Standard* means the Standard for the Flammability (Open-Flame) of Mattress Sets (16 CFR part 1633, subpart A).
( b ) The definition of terms set forth in the § 1633.2 of the Standard shall also apply to this section.
No: 14-064 October 6, 2014

CONTACT: Dave McIntyre, 301-415-8200 

NRC Reorganizes Materials and Waste Programs

The Nuclear Regulatory Commission has combined its two nuclear materials and waste 

program offices into one, completing a restructuring directed by the Commission in July to help the 

agency position itself to complete its work most effectively in the materials, waste and environmental 

areas.

Effective Oct. 5, programs housed in the Office of Federal and State Materials and 

Environmental Management Programs and the Office of Nuclear Material Safety and Safeguards are 

merged. The new office will retain the name of the Office of Nuclear Material Safety and Safeguards or 

NMSS, an office established by Congress when it created the NRC in 1974. The merger reflects 

changes in the NRC’s materials and waste management workload and an effort to integrate regulation 

of the front and back ends of the nuclear fuel cycle, as well as the agency’s goal to reduce costs and 

improve efficiency.

NRC’s materials and waste programs include many activities such as licensing facilities and 

devices that use radioactive materials; event assessment; source security; state and tribal programs; 

intergovernmental liaison and rulemaking; environmental review; waste management; the nuclear fuel 

cycle from uranium recovery through conversion, enrichment and fabrication; spent fuel storage, 

radioactive materials transportation; power plant and materials facility decommissioning, and 

environmental remediation. 

NMSS was split into the two offices in 2006, with FSME focused in part on coordinating with 

the increasing number of Agreement States that regulate radioactive materials. NMSS was focused on 

high-level waste management, storage and disposal in preparation for receiving the Yucca Mountain 

repository application, as well as regulating new fuel cycle facilities. Today, an increasing number of 

nuclear plants are moving to decommissioning, and the focus is shifting to long-term waste storage and 

disposal strategies. These functions will now all be housed in NMSS.

“The realignment will help us meet these demands while maintaining our ability to protect 

public health and safety and the environment,” said Mark Satorius, Executive Director for Operations. 

“We fully expect these changes to make us more efficient and improve our communications both inside 

and outside of the agency.”

Catherine Haney has been named director of the merged organization with Scott Moore as 

deputy director. Senior staff include Laura Dudes, director of the Division of Materials Safety and State 

Agreements; Mark Lombard, director of the Division of Spent Fuel Management; Marissa Bailey, 

director of the Division of Fuel Cycle Safety, Safeguards and Environmental Review; Larry Camper, 
Page | 2

director of the Division of Decommissioning, Uranium Recovery and Waste Programs; Josephine 

Piccone, director of the Yucca Mountain Directorate; and Andy Imboden, director of the Program 

Planning, Budgeting and Program Analysis staff.
EXHIBIT 32.2

                           CERTIFICATION OF PRINCIPAL
                          FINANCIAL OFFICER PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT BY
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Quarterly Report of Bekem Metals, Inc. on Form
10-QSB for the quarter ended September 30, 2006, as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), the undersigned,
Yermek Kudabayev, Principal Financial Officer of the Company, certify, pursuant
to 18 U.S.C. ss.1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act
of 2002, that:

         (1)      The Report fully complies with the requirements of section 13
                  (a) or 15 (d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and result of
                  operations of the Company.



Date: November 14, 2006                             /s/ Yermek Kudabayev
                                                    ----------------------------
                                                     Yermek Kudabayev,
                                                     Principal Financial Officer
Home > NRC Library > ADAMS Public Documents

# SECY-15-0135:  Annual Update of the Risk-Informed Activites Public Website

Accession Number: ML15267A837

Date Released: Thursday, November 12, 2015

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.
    - ML15267A860 - SECY-15-0135:  Annual Update of the Risk-Informed Activites Public Website (6 page(s), 10/27/2015)
    - ML15272A512 - SECY-15-0135:  Enclosure, 2015 Risk-Informed Activities List (24 page(s), 10/27/2015)

Privacy PolicySite Disclaimer
# L_2023106EN.01002601.xml

| 20.4.2023 | EN | Official Journal of the European Union | L 106/26 |
| --- | --- | --- | --- |

20.4.2023

EN

Official Journal of the European Union

L 106/26

---

DECISION OF THE EEA JOINT COMMITTEE No 240/2022

of 23 September 2022

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/769]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Implementing Regulation (EU) 2022/209 of 16 February 2022 establishing the format of the data to be collected and reported in order to determine the volume of sales and the use of antimicrobial medicinal products in animals in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Implementing Regulation (EU) 2022/209 of 16 February 2022 establishing the format of the data to be collected and reported in order to determine the volume of sales and the use of antimicrobial medicinal products in animals in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (1) is to be incorporated into the EEA Agreement.

| (2) | Annex II to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(2)

Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following point is inserted after point 22g (Commission Delegated Regulation (EU) 2021/1760) of Chapter XIII of Annex II to the EEA Agreement:

| ‘22h. | 32022 R 0209: Commission Implementing Regulation (EU) 2022/209 of 16 February 2022 establishing the format of the data to be collected and reported in order to determine the volume of sales and the use of antimicrobial medicinal products in animals in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (OJ L 35, 17.2.2022, p. 7).’ |
| --- | --- |

‘22h.

32022 R 0209: Commission Implementing Regulation (EU) 2022/209 of 16 February 2022 establishing the format of the data to be collected and reported in order to determine the volume of sales and the use of antimicrobial medicinal products in animals in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (OJ L 35, 17.2.2022, p. 7).’

Article 2

The text of Implementing Regulation (EU) 2022/209 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 24 September 2022, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 23 September 2022.

For the EEA Joint Committee

The President

Kristján Andri STEFÁNSSON

---

(1)  
  OJ L 35, 17.2.2022, p. 7.

1

(*)  No constitutional requirements indicated.

*

---